Paper39211666
Dorzagliatin: A Breakthrough Glucokinase Activator Coming on Board to Treat Diabetes Mellitus.
Raju R and 3 others. Cureus, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Dorzagliatin: A Breakthrough Glucokinase Activator Coming on Board to Treat Diabetes Mellitus. Papers, record 39211666. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39211666
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dorzagliatin: A Breakthrough Glucokinase Activator Coming on Board to Treat Diabetes Mellitus.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35551294 | Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial. | Nat Med | 2022 | https://conductscience.org/library/papers/35551294 | PubMed |
| 2 | 8954920 | Analysis of the pancreatic beta cell in the mouse with targeted disruption of the pancreatic beta cell-specific glucokinase gene. | Biochem Biophys Res Commun | 1996 | https://conductscience.org/library/papers/8954920 | PubMed |
| 3 | 5501259 | Glucose-induced electrical activity in pancreatic islet cells. | J Physiol | 1970 | https://conductscience.org/library/papers/5501259 | PubMed |
| 4 | 35067153 | Glucokinase as an emerging anti-diabetes target and recent progress in the development of its agonists. | J Enzyme Inhib Med Chem | 2022 | https://conductscience.org/library/papers/35067153 | PubMed |
| 5 | 29648519 | Glutamate dehydrogenase: role in regulating metabolism and insulin release in pancreatic β-cells. | J Appl Physiol (1985) | 2018 | https://conductscience.org/library/papers/29648519 | PubMed |
| 6 | 29735394 | Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study. | Lancet Diabetes Endocrinol | 2018 | https://conductscience.org/library/papers/29735394 | PubMed |
| 7 | 21994424 | Effects of MK-0941, a novel glucokinase activator, on glycemic control in insulin-treated patients with type 2 diabetes. | Diabetes Care | 2011 | https://conductscience.org/library/papers/21994424 | PubMed |
| 8 | 38203742 | New-Generation Glucokinase Activators: Potential Game-Changers in Type 2 Diabetes Treatment. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38203742 | PubMed |
| 9 | 12869762 | Allosteric activators of glucokinase: potential role in diabetes therapy. | Science | 2003 | https://conductscience.org/library/papers/12869762 | PubMed |
| 10 | 24739934 | Dynamic localization of glucokinase and its regulatory protein in hypothalamic tanycytes. | PLoS One | 2014 | https://conductscience.org/library/papers/24739934 | PubMed |
| 11 | 21525462 | Glucokinase activators for diabetes therapy: May 2010 status report. | Diabetes Care | 2011 | https://conductscience.org/library/papers/21525462 | PubMed |
| 12 | 9278411 | Effects of increased glucokinase gene copy number on glucose homeostasis and hepatic glucose metabolism. | J Biol Chem | 1997 | https://conductscience.org/library/papers/9278411 | PubMed |
| 13 | 36342518 | Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes. | Diabetes | 2023 | https://conductscience.org/library/papers/36342518 | PubMed |
| 14 | 25440507 | Adherence to diabetes medication: a systematic review. | Diabet Med | 2015 | https://conductscience.org/library/papers/25440507 | PubMed |
| 15 | 4870741 | Metabolism of glucose in the islets of Langerhans. | J Biol Chem | 1968 | https://conductscience.org/library/papers/4870741 | PubMed |
| 16 | 24606905 | Hypoglycemia-activated GLUT2 neurons of the nucleus tractus solitarius stimulate vagal activity and glucagon secretion. | Cell Metab | 2014 | https://conductscience.org/library/papers/24606905 | PubMed |
| 17 | 27422385 | Sex-Specific Control of Fat Mass and Counterregulation by Hypothalamic Glucokinase. | Diabetes | 2016 | https://conductscience.org/library/papers/27422385 | PubMed |
| 18 | 14060797 | EFFECTS OF CARBOHYDRATES ON SECRETION OF INSULIN FROM ISOLATED RAT PANCREAS. | Am J Physiol | 1963 | https://conductscience.org/library/papers/14060797 | PubMed |
| 19 | 25802718 | Present status of clinical deployment of glucokinase activators. | J Diabetes Investig | 2015 | https://conductscience.org/library/papers/25802718 | PubMed |
| 20 | 37385967 | Diabetes remission in drug-naïve patients with type 2 diabetes after dorzagliatin treatment: A prospective cohort study. | Diabetes Obes Metab | 2023 | https://conductscience.org/library/papers/37385967 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42791034 | Resetting the glucose sensor: dorzagliatin and the evolution of glucokinase activation in diabetes therapy. | BMJ Open Diabetes Res Care | 2026 | https://conductscience.org/library/papers/42791034 | PubMed |
| 41685165 | Activating protein kinases to treat diseases: Current understanding and future challenges. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/41685165 | PubMed |
| 41659332 | Dorzagliatin shows potential in preventing cognitive impairment in diabetes: evidence from Mendelian randomization analysis and animal study. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/41659332 | PubMed |
| 41599685 | TAT-PBX1 Reverses Hyperglycemia Through β-Cell Regeneration and Functional Restoration in an STZ-Induced Diabetic Model. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41599685 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GCK | 2645 | PubTator's text mining | https://conductscience.org/library/genes/2645 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39211666
GET https://conductscience.org/api/papers/v1/39211666/references?page=2